Related Experiment Video
Updated: Oct 29, 2025

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
Moving Fast Toward Hepatitis B Virus Elimination
Leda Bassit1, Suzane Kioko Ono2, Raymond F Schinazi3
1Center for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, and Children's Healthcare of Atlanta, Atlanta, GA, USA.
Current hepatitis B treatments control the virus but do not cure it, necessitating long-term therapy. New antiviral drugs targeting hepatitis B virus (HBV) replication are in development for a potential cure.
Area of Science:
- Hepatology and Virology
- Drug Discovery and Development
Background:
- Current chronic hepatitis B treatments, nucleoside analogs and interferon alpha, effectively control viral replication and improve survival.
- These therapies do not eliminate the hepatitis B virus (HBV), requiring long-term treatment and posing risks of viral rebound, fibrosis, and hepatocellular carcinoma.
Purpose of the Study:
- To explore novel antiviral agents for a potential cure of chronic hepatitis B.
- To identify new therapeutic strategies that address the limitations of current HBV treatments.
Main Methods:
- Review of current understanding of HBV replication, disease pathophysiology, and the role of covalently closed circular DNA (cccDNA).
- Identification of multiple HBV replication targets for novel drug development.
- Analysis of anti-HBV drug candidates currently in clinical trials (Phase 1/2) and preclinical stages.
Main Results:
- Several novel anti-HBV drug development strategies targeting HBV replication are under investigation.
- A number of these novel agents are progressing through clinical trials or preclinical development.
- Promising results indicate potential for new curative therapies.
Conclusions:
- The development of curative therapies for chronic hepatitis B is an active area of research.
- Novel drug discovery efforts are focused on targeting key aspects of HBV replication and persistence.
- Emerging therapeutic modalities offer hope for a future cure for hepatitis B virus infection.
More Related Videos
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
09:35Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
Related Concept Videos
Viruses with RNA Genomes
Retrovirus Life Cycles
Drug Elimination: Non-Renal Routes
Hepatic Drug Excretion: Enterohepatic Cycling
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Enhanced Elimination of Poison
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy